297 related articles for article (PubMed ID: 11834884)
21. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
Ozaki H; Hayashi H; Oshima K
Ophthalmic Res; 1996; 28(6):356-60. PubMed ID: 9032794
[TBL] [Abstract][Full Text] [Related]
22. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
[TBL] [Abstract][Full Text] [Related]
23. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
24. CORRELATION OF INCREASED INTRAVITREOUS WNT3A WITH VASCULAR ENDOTHELIAL GROWTH FACTOR IN PROLIFERATIVE DIABETIC RETINOPATHY.
Gao X; Ma K; Lu N; Hong T; Xu Y; Peng X
Retina; 2016 Apr; 36(4):812-8. PubMed ID: 26418446
[TBL] [Abstract][Full Text] [Related]
25. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
26. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
Armstrong D; Augustin AJ; Spengler R; Al-Jada A; Nickola T; Grus F; Koch F
Ophthalmologica; 1998; 212(6):410-4. PubMed ID: 9787233
[TBL] [Abstract][Full Text] [Related]
27. Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis.
Schmidt NO; Westphal M; Hagel C; Ergün S; Stavrou D; Rosen EM; Lamszus K
Int J Cancer; 1999 Feb; 84(1):10-8. PubMed ID: 9988225
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor levels in vitreous and serum of patients with either proliferative diabetic retinopathy or proliferative vitreoretinopathy.
Sydorova M; Lee MS
Ophthalmic Res; 2005; 37(4):188-90. PubMed ID: 15990461
[TBL] [Abstract][Full Text] [Related]
29. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
[TBL] [Abstract][Full Text] [Related]
30. Stimulation and inhibition of angiogenesis in diabetic retinopathy.
Funatsu H; Yamashita H; Noma H; Shimizu E; Yamashita T; Hori S
Jpn J Ophthalmol; 2001; 45(6):577-84. PubMed ID: 11754898
[TBL] [Abstract][Full Text] [Related]
31. Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy.
Gao X; Ma K; Lu N; Xu Y; Hong T; Peng X
Mol Vis; 2015; 21():665-72. PubMed ID: 26120271
[TBL] [Abstract][Full Text] [Related]
32. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
Miller JW; Adamis AP; Shima DT; D'Amore PA; Moulton RS; O'Reilly MS; Folkman J; Dvorak HF; Brown LF; Berse B
Am J Pathol; 1994 Sep; 145(3):574-84. PubMed ID: 7521577
[TBL] [Abstract][Full Text] [Related]
34. Expression of angiopoietin-like protein 8 correlates with VEGF in patients with proliferative diabetic retinopathy.
Lu Q; Lu L; Chen W; Lu P
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1515-1523. PubMed ID: 28456825
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N
Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359
[TBL] [Abstract][Full Text] [Related]
36. Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.
Wells JA; Murthy R; Chibber R; Nunn A; Molinatti PA; Kohner EM; Gregor ZJ
Br J Ophthalmol; 1996 Apr; 80(4):363-6. PubMed ID: 8703891
[TBL] [Abstract][Full Text] [Related]
37. [Concentration of vascular endothelial growth factor within the subretinal space and vitreous fluid in rhegmatogenous retinal detachment].
Moromizato Y; Hayashi H; Kato H; Ozaki H; Oshima K
Nippon Ganka Gakkai Zasshi; 1997 Jun; 101(6):498-502. PubMed ID: 9209137
[TBL] [Abstract][Full Text] [Related]
38. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease.
Briggs MC; Grierson I; Hiscott P; Hunt JA
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3085-94. PubMed ID: 10967068
[TBL] [Abstract][Full Text] [Related]
39. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
40. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
Funatsu H; Yamashita H; Noma H; Mochizuki H; Mimura T; Ikeda T; Hori S
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
